Over 2 years (FY 2021 to FY 2025), Business Sale Proceeds shows a downward trend with a -100.0% CAGR.
An increase signals portfolio optimization or a strategic pivot, while a lack of proceeds suggests a stable, long-term asset base.
This metric represents the cash inflows received from the divestiture or sale of business segments, product lines, or su...
Occurs sporadically; peers often divest legacy segments to focus on high-margin innovation areas like continuous glucose monitoring or diagnostics.
proceeds_from_sale_of_business| Q4 '21 | Q1 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | -$2.00M | $8.00M | $4.00M | $4.00M | $43.00M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $1.00M |
| QoQ Change | — | — | +500.0% | -50.0% | +0.0% | +975.0% | -100.0% | — | — | — | — | — | — | — | — |
| YoY Change | — | — | — | +300.0% | — | — | -100.0% | -100.0% | -100.0% | — | — | — | — | — | — |